http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008156270-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d09ebd6f16fda5adc4273e1f4c6f4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1018136c9ced19c153020691176b292e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce505c5df5e2a37cd22d255981efa6f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca0b1e96722a3a834aea3d73bca86f03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd15fea28fa5c3272dd3e41dcf3b0dd3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-18
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-28
filingDate 2008-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe2c393875e97d0761c0ae1226f4e8e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_499f027c7f94a6033b40371d118e4bbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62537804c63dc5803c4cb63412b2fa96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edd30f81cd37f8df26936917daa5e367
publicationDate 2009-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008156270-A3
titleOfInvention Gold-coated stent coated/plated the chemicals and oligonucleotide binding gold-coated stent and process for producing the same
abstract The present invention relates to a gold-plated stent and its preparation method. More specifically, it relates to a gold- plated stent that is coated with various chemical materials such as 2-aminoalkanethiol, epihalogenhydrin, and diamine compounds in a sequence and also oligonucleotide gold-plated stent, which is prepared by binding oligonucleotide, a biomaterial, to the gold- plated stent coated with said chemicals. The oligonucleotide gold-plated stent of the present invention has an advantages of raising the local concentration in injured parts and minimizing the toxicity overall the body, so it can be used for prevention of restenosis after angioplasty.
priorityDate 2007-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6767944-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004063654-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5464650-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6712846-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6398806-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985

Total number of triples: 30.